Effect of menses on standardized assessment of sexual dysfunction among women with uterine fibroids: A cohort study

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective To determine if assessment of sexual dysfunction by the Female Sexual Function Index (FSFI) is related to whether the FSFI is administered during or between menses, in women with symptomatic uterine fibroids. Design Prospective cohort. Setting Academic medical centers. Patient(s) Premenopausal women who had symptomatic uterine fibroids and were enrolled in fibroid treatment trials. Intervention(s) Administration of FSFI during and between menses. Main Outcome Measure(s) Mean FSFI scores in each of 6 domains, and a discordance score to report individual differences in assessment. Result(s) Thirty-three women completed the FSFI, during menstruation, and at a time in their cycle when they were not menstruating. The mean FSFI scores for each domain did not differ based on when in the menstrual cycle the instrument was administered. However, on an individual level, nearly half of the women reported sexual dysfunction differently during menses than between menses. Of those that reported differences, the pain and desire domains improved; the lubrication and satisfaction domains worsened during menses. Conclusion(s) Although the mean values of the domain scores were not different, women did report differences in sexual functioning during vs. between menses. Timing of the questionnaire in relation to menses should be considered in sexual-dysfunction assessment for women with uterine fibroids. Clinical Trials Registration Number NCT00995878.

Original languageEnglish (US)
Pages (from-to)435-439
Number of pages5
JournalFertility and Sterility
Volume104
Issue number2
DOIs
StatePublished - Aug 1 2015

Fingerprint

Menstruation
Leiomyoma
Cohort Studies
Lubrication
Menstrual Cycle
Individuality
Outcome Assessment (Health Care)
Clinical Trials
Pain

Keywords

  • Female Sexual Function Index
  • fibroid
  • Leiomyoma
  • sexual function

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

@article{a6329bb4d4304978a3420d8fe99fe57a,
title = "Effect of menses on standardized assessment of sexual dysfunction among women with uterine fibroids: A cohort study",
abstract = "Objective To determine if assessment of sexual dysfunction by the Female Sexual Function Index (FSFI) is related to whether the FSFI is administered during or between menses, in women with symptomatic uterine fibroids. Design Prospective cohort. Setting Academic medical centers. Patient(s) Premenopausal women who had symptomatic uterine fibroids and were enrolled in fibroid treatment trials. Intervention(s) Administration of FSFI during and between menses. Main Outcome Measure(s) Mean FSFI scores in each of 6 domains, and a discordance score to report individual differences in assessment. Result(s) Thirty-three women completed the FSFI, during menstruation, and at a time in their cycle when they were not menstruating. The mean FSFI scores for each domain did not differ based on when in the menstrual cycle the instrument was administered. However, on an individual level, nearly half of the women reported sexual dysfunction differently during menses than between menses. Of those that reported differences, the pain and desire domains improved; the lubrication and satisfaction domains worsened during menses. Conclusion(s) Although the mean values of the domain scores were not different, women did report differences in sexual functioning during vs. between menses. Timing of the questionnaire in relation to menses should be considered in sexual-dysfunction assessment for women with uterine fibroids. Clinical Trials Registration Number NCT00995878.",
keywords = "Female Sexual Function Index, fibroid, Leiomyoma, sexual function",
author = "Laughlin-Tommaso, {Shannon K} and Borah, {Bijan J} and Stewart, {Elizabeth A}",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.fertnstert.2015.04.029",
language = "English (US)",
volume = "104",
pages = "435--439",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Effect of menses on standardized assessment of sexual dysfunction among women with uterine fibroids

T2 - A cohort study

AU - Laughlin-Tommaso, Shannon K

AU - Borah, Bijan J

AU - Stewart, Elizabeth A

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Objective To determine if assessment of sexual dysfunction by the Female Sexual Function Index (FSFI) is related to whether the FSFI is administered during or between menses, in women with symptomatic uterine fibroids. Design Prospective cohort. Setting Academic medical centers. Patient(s) Premenopausal women who had symptomatic uterine fibroids and were enrolled in fibroid treatment trials. Intervention(s) Administration of FSFI during and between menses. Main Outcome Measure(s) Mean FSFI scores in each of 6 domains, and a discordance score to report individual differences in assessment. Result(s) Thirty-three women completed the FSFI, during menstruation, and at a time in their cycle when they were not menstruating. The mean FSFI scores for each domain did not differ based on when in the menstrual cycle the instrument was administered. However, on an individual level, nearly half of the women reported sexual dysfunction differently during menses than between menses. Of those that reported differences, the pain and desire domains improved; the lubrication and satisfaction domains worsened during menses. Conclusion(s) Although the mean values of the domain scores were not different, women did report differences in sexual functioning during vs. between menses. Timing of the questionnaire in relation to menses should be considered in sexual-dysfunction assessment for women with uterine fibroids. Clinical Trials Registration Number NCT00995878.

AB - Objective To determine if assessment of sexual dysfunction by the Female Sexual Function Index (FSFI) is related to whether the FSFI is administered during or between menses, in women with symptomatic uterine fibroids. Design Prospective cohort. Setting Academic medical centers. Patient(s) Premenopausal women who had symptomatic uterine fibroids and were enrolled in fibroid treatment trials. Intervention(s) Administration of FSFI during and between menses. Main Outcome Measure(s) Mean FSFI scores in each of 6 domains, and a discordance score to report individual differences in assessment. Result(s) Thirty-three women completed the FSFI, during menstruation, and at a time in their cycle when they were not menstruating. The mean FSFI scores for each domain did not differ based on when in the menstrual cycle the instrument was administered. However, on an individual level, nearly half of the women reported sexual dysfunction differently during menses than between menses. Of those that reported differences, the pain and desire domains improved; the lubrication and satisfaction domains worsened during menses. Conclusion(s) Although the mean values of the domain scores were not different, women did report differences in sexual functioning during vs. between menses. Timing of the questionnaire in relation to menses should be considered in sexual-dysfunction assessment for women with uterine fibroids. Clinical Trials Registration Number NCT00995878.

KW - Female Sexual Function Index

KW - fibroid

KW - Leiomyoma

KW - sexual function

UR - http://www.scopus.com/inward/record.url?scp=84938286999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938286999&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2015.04.029

DO - 10.1016/j.fertnstert.2015.04.029

M3 - Article

C2 - 25989973

AN - SCOPUS:84938286999

VL - 104

SP - 435

EP - 439

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -